tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Crinetics Pharmaceuticals (CRNX) Stock Investors

413 Followers
Based on 732,952 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CRNX
On average, investors allocate 3.47% of their portfolios to CRNX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 732,952 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CRNX

0.4%
Last 7
Days
5.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CRNX, out of 732,952 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CRNX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
2.65%
$40.47
Opened
0.29%
$34.75
Opened
1.17%
$31.81
Reduced
1.72%
$43.76
Opened
0.00%
$30.22
Reduced
0.09%
$44.97
Opened
7.69%
$29.99
Based on the activity of 13,790 investors who made their portfolios public
The table shows changes in CRNX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CRNX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.64%
-2.99%
-6.56%
255.37M
Healthcare
Merck & Company
4.12%
-2.25%
-0.62%
330.23B
Healthcare
Marvell
4.86%
-2.05%
+2.17%
59.48B
Technology
Block
4.42%
-1.15%
-3.54%
44.18B
Technology
Micron
5.74%
-1.01%
+2.25%
132.01B
Technology
Trade Desk
4.77%
-1.10%
-1.94%
43.83B
Technology
GE Aerospace
5.49%
-0.97%
+5.47%
184.75B
Industrials
ServiceNow
3.90%
-0.81%
+1.13%
146.23B
Technology
Mastercard
4.66%
-1.01%
+1.74%
421.33B
Financial
AbbVie
5.59%
-1.43%
+0.42%
287.04B
Healthcare
Based on the activity of 732,952 active portfolios
Open your Smart Portfolio

CRNX Investor Analysis

CRNX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.9%
of CRNX holders
are under 35
Average Segment Performance
Average P/E Ratio52.24
Beta6.32
Dividend Yield6.28%
CRNX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
51.0%
of CRNX holders
are between 35–55
Average Segment Performance
Average P/E Ratio56.33
Beta11.09
Dividend Yield19.22%
CRNX investors over 55

Over 55

10.9%
Last 30 days
Holdings Change
43.1%
of CRNX holders
are over 55
Average Segment Performance
Average P/E Ratio47.15
Beta3.97
Dividend Yield6.60%
Overview of age group and performance of CRNX stock investors
See who invests in CRNX according to age group and performance.

FAQ

How many retail Investors hold CRNX?
<0.1% of TipRanks' retail investors hold CRNX in their portfolios.
    What is CRNX Investor Sentiment?
    CRNX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CRNX in the last 7 days?
      ▼ 0.4% of TipRanks' retail investors changed their holding of CRNX in the last 7 days.
        What percentage of retail investors changed their holding of CRNX in the last 30 days?
        ▼ 5.6% of TipRanks' retail investors changed their holding of CRNX in the last 30 days.
          What is the average age of retail investors who hold CRNX?
          The average age of CRNX Holders is between 35–55.
            What other stocks have CRNX investors also bought?
            CRNX Investors also bought CHRS, MRK, MRVL, SQ, MU, TTD, GE, NOW, MA, ABBV.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CYTKCytokinetics
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis